hyperimmune caprine serum
Animal productexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00769028)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hyperimmune caprine serum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01228396 | Phase 2 | May 1, 2009 | Daval International Limited, University of London |
| NCT00769028 | Phase 2 | Dec 1, 2008 | Daval International Limited, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daval International Limited | For profit | 2 | 2 | 1 | 2008 |
| University of London | Academic/Hospital | 2 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1